MedTrace Logo

Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.

NCT03547869 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-02-03

Study results available
· View outcomes & findings →

Summary

The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.

Conditions

  • Gulf War Syndrome

Interventions

DEVICE

Active tDCS

Active tDCS will be adminestered

DEVICE

Sham tDCS

Sham tDCS will be administered

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • The University of Texas at Dallas

    lead OTHER

Principal Investigators

  • Sven Vanneste, PhD · The University of Texas at Dallas

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-12
Primary Completion
2022-01-25
Completion
2023-01-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547869 on ClinicalTrials.gov